Startup profile · funding coverage
Talkiatry funding, valuation and investors
In-network telepsychiatry platform for value-based behavioral health.
Keep track of Talkiatry
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C
$130M · June 2024
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$205M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, NY
Investors in latest funding
Lead: Andreessen Horowitz
Overview
Talkiatry is a national mental health practice providing in-network psychiatry and therapy through telehealth. Co-founded in 2020 by a patient and triple-board-certified psychiatrist, the company built technology and operations to make psychiatrists in-network while delivering outcomes-based care for health plans. In June 2024, Talkiatry announced $130 million in equity and debt financing led by Andreessen Horowitz, with Perceptive Advisors and Banc of California debt participation — bringing total funding to $245 million. The company reports over one million patient visits and partnerships with expanding payer networks.
Why Talkiatry is interesting
Talkiatry proved psychiatric care can run in risk-based payer contracts — a16z-led $130M Series C after cutting hospitalizations 68% for a national health plan.
Product & use cases
Talkiatry delivers virtual psychiatry and therapy covered by major insurers, with operational tooling that lets psychiatrists stay in-network and health plans adopt risk-based behavioral health arrangements.
- Adults seeking in-network psychiatric care via telehealth
- Health plans reducing ER visits and hospitalizations through managed psychiatry
- Employers offering covered mental health access beyond EAP checkboxes
Key facts
- Series C (Jun 2024): $130M led by a16z; $245M total raised (PR Newswire)
- Named Fierce 15 in 2024; 1M+ patient visits reported
- Value-based outcomes: 68% hospitalization reduction cited for national health plan
- Co-founded by patient and psychiatrist to fix access and reimbursement gaps
Funding history (newest first)
Investors in our directory
Funds linked from Talkiatry's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Dual-sided model aligning psychiatrist reimbursement with payer value-based contracts — rare operational depth in telepsychiatry at scale.
Telepsychiatry is crowded post-COVID, but Talkiatry's payer outcomes data — 68% hospitalization reduction cited for one national plan — supports value-based pricing. Scale requires psychiatrist supply and payer contracting velocity.
-
Headway direct
Therapist/psychiatrist in-network matching; overlapping payer partnerships.
-
Lyra Health adjacent
Employer-sponsored mental health benefit; less psychiatry-first.
-
Traditional in-person psychiatry incumbent
Long wait times; many providers out-of-network.
Notable stories
- Talkiatry's Series C pitch centered on saving $700 per member per month versus peers for a leading national health plan — moving psychiatry from fee-for-service telehealth to contracted outcomes (PR Newswire, Jun 2024).
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Talkiatry's financing or category context.
FAQs about Talkiatry
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.